Wu Y - Search Results

1

[miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].

Zhang S, Wu Y, Feng D, Zhang Z, Jiang F, Yin R, Xu L. Zhang S, et al. Among authors: wu y. Zhongguo Fei Ai Za Zhi. 2011 Apr;14(4):317-22. doi: 10.3779/j.issn.1009-3419.2011.04.03. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21496429 Free PMC article. Chinese.

2

microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.

Yin R, Zhang S, Wu Y, Fan X, Jiang F, Zhang Z, Feng D, Guo X, Xu L. Yin R, et al. Among authors: wu y. Oncol Rep. 2011 Jun;25(6):1747-54. doi: 10.3892/or.2011.1252. Epub 2011 Apr 7. Oncol Rep. 2011. PMID: 21479367

3

Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis.

Zhang L, Wang J, Xu L, Zhou J, Guan X, Jiang F, Wu Y, Fan W. Zhang L, et al. Among authors: wu y. Mutagenesis. 2012 Jan;27(1):67-76. doi: 10.1093/mutage/ger062. Epub 2011 Oct 13. Mutagenesis. 2012. PMID: 22002622

4

The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.

Zhang LQ, Jiang F, Xu L, Wang J, Bai JL, Yin R, Wu YQ, Meng LJ. Zhang LQ, et al. Clin Lung Cancer. 2012 May;13(3):188-95. doi: 10.1016/j.cllc.2011.10.003. Epub 2011 Dec 1. Clin Lung Cancer. 2012. PMID: 22133292 Review.

5

Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemia-reperfusion injury.

Wu Y, Lv J, Feng D, Jiang F, Fan X, Zhang Z, Yin R, Xu L. Wu Y, et al. Int J Mol Med. 2012 Dec;30(6):1294-306. doi: 10.3892/ijmm.2012.1161. Epub 2012 Oct 16. Int J Mol Med. 2012. PMID: 23076613

6

Lack of association between hsa-miR-149 rs2292832 polymorphism and cancer risk: a meta-analysis of 12 studies.

Xu L, Zhou X, Qiu MT, Yin R, Wu YQ, Xu L. Xu L, et al. PLoS One. 2013 Sep 5;8(9):e73762. doi: 10.1371/journal.pone.0073762. eCollection 2013. PLoS One. 2013. PMID: 24040059 Free PMC article.

7

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.

Shi R, Zhang C, Wu Y, Wang X, Sun Q, Sun J, Xia W, Dong G, Wang A, Jiang F, Xu L. Shi R, et al. Among authors: wu y. Oncotarget. 2017 Mar 21;8(12):19768-19779. doi: 10.18632/oncotarget.15519. Oncotarget. 2017. PMID: 28423619 Free PMC article.

8

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer.

Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L. Wu Y, et al. Onco Targets Ther. 2018 Mar 28;11:1707-1720. doi: 10.2147/OTT.S157440. eCollection 2018. Onco Targets Ther. 2018. PMID: 29636620 Free PMC article.

9

SNAP23 suppresses cervical cancer progression via modulating the cell cycle.

Zhu B, Zhang Q, Wu Y, Luo J, Zheng X, Xu L, Lu E, Qu J, Ren B. Zhu B, et al. Among authors: wu y. Gene. 2018 Oct 5;673:217-224. doi: 10.1016/j.gene.2018.06.028. Epub 2018 Jun 23. Gene. 2018. PMID: 29908998

10

Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.

Wu Y, Huang J, Xu H, Gong Z. Wu Y, et al. Biomed Pharmacother. 2018 Sep;105:1325-1334. doi: 10.1016/j.biopha.2018.06.033. Epub 2018 Jun 26. Biomed Pharmacother. 2018. PMID: 30021370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,440 results

Search Page

Filters